Net profit of Welcure Drugs & Pharmaceuticals reported to Rs 1.84 crore in the quarter ended September 2024 as against net loss of Rs 0.10 crore during the previous quarter ended September 2023. Sales reported to Rs 24.55 crore in the quarter ended September 2024. There were no Sales reported during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales24.550 0 OPM %7.540 - PBDT1.85-0.09 LP PBT1.84-0.10 LP NP1.84-0.10 LP Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals has revised the meeting of the Board of Directors which was scheduled to be held on 13 November 2024. The meeting will now be held on 14 November 2024.Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 21 October 2024.Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News